Fibrinogen Blood Test: Normal Range, High & Low Levels

Fibrinogen is a blood protein with a double life. It is a clotting factor — coagulation factor I, the precursor of the fibrin mesh that holds a clot together — and an acute-phase reactant, an inflammation protein that rises in the blood the same way CRP does. That double nature is the key to reading the number: a high fibrinogen usually reflects inflammation, infection, or pregnancy far more often than anything dangerous, while a low fibrinogen points toward the liver, a consuming process such as DIC, or heavy bleeding — and carries a real bleeding risk. This guide covers the normal fibrinogen level in mg/dL, what high and low fibrinogen levels mean, their causes, and how the test fits with the rest of a coagulation work-up.

Key takeaways

• Fibrinogen is coagulation factor I, a protein made by the liver. Thrombin converts it into fibrin, the insoluble mesh that binds a clot together — the last brick of hemostasis.¹²
• Typical adult range: ≈ 200–400 mg/dL (equivalent to 2–4 g/L). It varies by laboratory and method, so read the interval printed on your report.³¹
• Fibrinogen is an acute-phase reactant: it climbs with inflammation, infection, pregnancy, estrogen, smoking, and age — the same behavior as CRP and ferritin. So a high fibrinogen most often means inflammation.¹⁴
• A high value is also studied as an independent cardiovascular risk marker, but — like CRP — it is a marker, not a treatment target on its own.⁵⁶
• A low fibrinogen is the one that bleeds: DIC, severe liver failure, congenital afibrinogenemia/dysfibrinogenemia, thrombolytic therapy, or massive transfusion. Low fibrinogen + prolonged PT/INR and aPTT + high D-dimer is the DIC picture.⁷⁸
• Fibrinogen is measured by the Clauss assay and is never read alone — always with PT/INR, aPTT, platelets, D-dimer, and CRP.³

Normal fibrinogen levels

These are indicative adult reference values. They depend on the laboratory and the assay (most labs use the Clauss method), so trust the interval printed on your report.¹³

On units. U.S. labs usually report fibrinogen in mg/dL; the conversion is simple — 200 mg/dL = 2 g/L, so divide by 100 to get g/L. Pregnancy naturally raises fibrinogen (often to 400–600 mg/dL by the third trimester), so a "high" value there is expected. In major hemorrhage, clinicians aim to keep fibrinogen above roughly 150 mg/dL.⁹

What is fibrinogen?

Fibrinogen is a large protein made by the liver and carried in high concentration in the blood. When a vessel is injured, the coagulation cascade fires; at its end, an enzyme called thrombin converts soluble fibrinogen into fibrin, a web of insoluble threads that traps platelets and red cells to build a stable clot. Without enough fibrinogen, the clot cannot "set" — it is the final structural step of hemostasis.¹²

But fibrinogen has a second job that is easy to miss: it is an acute-phase reactant. Like CRP, the liver ramps up its production during inflammation or infection, so its blood level rises, sometimes sharply. This double identity is why the same number can speak to clotting or to inflammation depending on context — and why it is never interpreted in isolation.

Fibrinogen versus fibrin. Fibrinogen is the soluble form that circulates; fibrin is its converted, insoluble form that makes up the clot. When a clot is later broken down, it releases fragments — the D-dimers.

Fibrinogen is an acute-phase reactant

This is the single most important idea for reading your result. Acute-phase reactants are proteins the liver produces more of during inflammation, and fibrinogen is one of the classic ones — alongside CRP and ferritin.¹ The practical consequence: fibrinogen goes up with inflammation, infection, tissue injury, pregnancy, estrogen (including oral contraceptives and hormone therapy), smoking, and simply with older age.⁴³

So when a report shows a high fibrinogen, the first explanation is usually not a clotting problem but an inflammatory state — exactly the situations that also raise CRP and the erythrocyte sedimentation rate. That is also why a fibrinogen level is far more informative read next to CRP than on its own: two acute-phase proteins moving together point coherently at inflammation.

Why is the test done?

A clinician may order a fibrinogen level to:³²

• work up a bleeding or clotting disorder — unexplained bleeding, or a screening abnormality — usually together with PT/INR and aPTT;
• diagnose or follow a serious consuming process such as disseminated intravascular coagulation (DIC), where clotting factors are used up;⁸
• help assess liver disease, since the liver makes fibrinogen (read alongside ALT);
• monitor coagulation during pregnancy, delivery, or major hemorrhage, and guide fibrinogen replacement in bleeding surgical or trauma patients;⁹¹⁰
• occasionally, as a research-supported cardiovascular risk marker — though not as a standalone screen.⁵

Fibrinogen needs no fasting and can be drawn at any time, including in the emergency room. Correct filling of the citrated (blue-top) tube matters more to the result than any prep.²

Interpreting your results

Fibrinogen is never read alone. Interpret it with PT/INR, aPTT, platelets, D-dimer, CRP, and — above all — the clinical picture.

High fibrinogen

A high fibrinogen (above ~400 mg/dL) most often reflects its role as an acute-phase reactant. The common causes:⁴³

• inflammation or infection — fibrinogen rises like CRP, and can stay up for days;
• pregnancy, which raises fibrinogen physiologically — expected, not alarming;
• smoking, older age, obesity, estrogen use, chronic stress, and the period after surgery or trauma.

High fibrinogen is also an associated cardiovascular risk factor. The large Fibrinogen Studies Collaboration meta-analysis found a continuous association between plasma fibrinogen and the risk of coronary heart disease and stroke,⁵ and Mendelian-randomization work suggests genetically higher fibrinogen may contribute to ischemic stroke risk.⁶ The structure of the fibrin clot itself — dense, lysis-resistant networks — tracks with worse cardiovascular outcomes.⁴ But avoid the trap: fibrinogen is a marker, not a target you lower with a drug. You act on the underlying risk factors (smoking, blood pressure, cholesterol, diabetes), not on the number.

What to do about a mildly high fibrinogen? Often nothing urgent. A modestly elevated, isolated value in someone with a recent infection, ongoing inflammation, or a pregnancy is unremarkable — the context (CRP, symptoms, history) guides. A high fibrinogen is not a cancer screening test; it signals inflammation, not a tumor.

Low fibrinogen

A low fibrinogen (below ~200 mg/dL) is the more worrying direction, because it hits the clotting-factor role: less fibrinogen means a clot that sets poorly, so a bleeding risk. Causes include:⁷¹

• severe liver disease (cirrhosis, liver failure): the liver makes less fibrinogen (a synthesis problem), read alongside ALT;
• DIC (disseminated intravascular coagulation): fibrinogen is consumed by runaway clotting (sepsis, obstetric emergency, cancer, major trauma) — a serious state with prolonged PT/INR, low platelets, and very high D-dimer;⁸
• massive hemorrhage or dilution (large transfusions, fluid resuscitation) that exhausts fibrinogen;⁹
• excessive fibrinolysis (the clot is dissolved too fast), including thrombolytic ("clot-buster") therapy;
• rare congenital disorders — afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia.¹¹

When should you worry? It is not the number alone but its level, its rate of fall, and the context. A very low fibrinogen — in practice below ~100–150 mg/dL, especially if it is dropping quickly or there is active bleeding — needs prompt medical care. In severe hemorrhage (cardiac surgery, trauma, postpartum bleeding), fibrinogen can be replaced with fibrinogen concentrate or cryoprecipitate; the randomized FIBRES trial showed fibrinogen concentrate was non-inferior to cryoprecipitate after cardiac surgery.⁹¹² These decisions belong strictly to the treating physician.

Fibrinogen, D-dimer, and DIC

Fibrinogen earns its meaning when cross-referenced. The tightest example is DIC, where fibrinogen and D-dimer tell opposite halves of the same story:

• fibrinogen falls as it is consumed by widespread clotting;
• D-dimer rises because all that fibrin is simultaneously being broken down;
• PT/INR and aPTT lengthen, and platelets drop.

Put together — low fibrinogen + high D-dimer + prolonged PT and aPTT + low platelets — that pattern is the classic DIC signature, and it is exactly what the 2025 ISTH diagnostic criteria weigh, distinguishing more bleeding (consumptive) from more thrombotic forms.⁸⁷ The same markers, read against a very different clinical background, also help separate DIC from the coagulopathy of liver disease.¹³ It is this combination — not any single value — that carries the diagnosis.

What can affect your fibrinogen

Many things move fibrinogen. Upward: inflammation and infection, pregnancy, estrogen (oral contraceptives, hormone therapy), smoking, older age, obesity, and the post-surgical or post-trauma state. Downward: severe liver disease, consumption (DIC), massive hemorrhage or dilution, thrombolytic drugs, and rare congenital deficiencies. Pre-analytic factors matter too: the citrated tube must be filled correctly and processed on time, or the result is unreliable. Tell your clinician if you are pregnant, on estrogen, a smoker, or recovering from a recent infection — each changes how the number reads.

Recent research

From recent PubMed publications and trial registries:

• Fibrinogen and cardiovascular risk. The Fibrinogen Studies Collaboration individual-participant meta-analysis (JAMA, 2005) established a continuous association between plasma fibrinogen and coronary heart disease, stroke, and vascular mortality — the classic evidence that fibrinogen is a cardiovascular risk marker.⁵ A 2024/2025 Mendelian-randomization analysis further suggests higher fibrinogen may causally contribute to ischemic stroke, and fibrin clot structure itself tracks cardiovascular prognosis.⁶⁴
• DIC criteria, updated. In 2025 the International Society on Thrombosis and Haemostasis (ISTH) released a new definition and diagnostic criteria for DIC, confirming the roles of fibrinogen, platelets, PT/INR, and D-dimer and separating predominantly hemorrhagic from thrombotic phenotypes.⁸
• Replacing fibrinogen when patients bleed. The randomized FIBRES trial (JAMA, 2019) found fibrinogen concentrate non-inferior to cryoprecipitate for reducing transfusion after cardiac surgery in patients with acquired low fibrinogen; later analysis supported its cost-effectiveness.⁹¹²
• Fibrinogen in pregnancy. A low pre-delivery fibrinogen predicts postpartum hemorrhage, and the ISTH has issued guidance on managing congenital fibrinogen disorders through pregnancy and delivery.¹⁰¹¹

These findings concern diagnosis and medical management; they do not replace your physician's advice.

Get your fibrinogen interpreted by AI DiagMe

A fibrinogen is never read alone: its meaning depends on its level, your context (pregnancy, infection, liver disease, smoking), and your other markers — PT/INR, aPTT, platelets, D-dimer, and CRP. That cross-referencing is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

Bottom line

Fibrinogen is a protein with a double role: a clotting factor (factor I, the precursor of fibrin) and an acute-phase reactant that rises with inflammation, just like CRP. Remember the range (normal ≈ 200–400 mg/dL, lab-dependent), that a high fibrinogen usually means inflammation, infection, or pregnancy — and stays a marker, not a target — and that a low fibrinogen (liver, DIC, hemorrhage, congenital) carries a bleeding risk when very low. Everything is in the cross-reference: read alongside PT/INR, aPTT, D-dimer, and CRP, it becomes genuinely useful — which is exactly what AI DiagMe provides, alongside your physician.

Sources

Official sources and peer-reviewed publications (PubMed, ClinicalTrials.gov) used for this guide: